IL2 and inflammatory bowel disease: For instance, Eudragit-encapsulated ECN, which was engineered to express interleukin-2 (ECN-IL2), demonstrated robust intestinal retention, significantly activated Tregs, and promoted epithelial barrier repair in DSS-induced IBD models.